Form 8-K - Current report:
SEC Accession No. 0001104659-21-037220
Filing Date
2021-03-16
Accepted
2021-03-16 17:16:57
Documents
55
Period of Report
2021-03-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm219663d1_8k.htm   iXBRL 8-K 30079
2 EXHIBIT 1.1 tm219663d1_ex1-1.htm EX-1.1 231922
3 EXHIBIT 5.1 tm219663d1_ex5-1.htm EX-5.1 8981
4 EXHIBIT 99.1 tm219663d1_ex99-1.htm EX-99.1 38216
5 EXHIBIT 99.2 tm219663d1_ex99-2.htm EX-99.2 7733
9 GRAPHIC image_001.jpg GRAPHIC 2557
10 GRAPHIC image_002.jpg GRAPHIC 193890
11 GRAPHIC image_003.jpg GRAPHIC 331802
12 GRAPHIC image_004.jpg GRAPHIC 242232
13 GRAPHIC image_005.jpg GRAPHIC 214523
14 GRAPHIC image_006.jpg GRAPHIC 95145
15 GRAPHIC image_007.jpg GRAPHIC 185843
16 GRAPHIC image_008.jpg GRAPHIC 287357
17 GRAPHIC image_009.jpg GRAPHIC 185385
18 GRAPHIC image_010.jpg GRAPHIC 117003
19 GRAPHIC image_011.jpg GRAPHIC 292406
20 GRAPHIC image_012.jpg GRAPHIC 233405
21 GRAPHIC image_013.jpg GRAPHIC 94201
22 GRAPHIC image_014.jpg GRAPHIC 337661
23 GRAPHIC image_015.jpg GRAPHIC 114406
24 GRAPHIC image_016.jpg GRAPHIC 183846
25 GRAPHIC image_017.jpg GRAPHIC 146440
26 GRAPHIC image_018.jpg GRAPHIC 133057
27 GRAPHIC image_019.jpg GRAPHIC 221210
28 GRAPHIC image_020.jpg GRAPHIC 105584
29 GRAPHIC image_021.jpg GRAPHIC 93815
30 GRAPHIC image_022.jpg GRAPHIC 233916
31 GRAPHIC image_023.jpg GRAPHIC 206818
32 GRAPHIC image_024.jpg GRAPHIC 172979
33 GRAPHIC image_025.jpg GRAPHIC 206550
34 GRAPHIC image_026.jpg GRAPHIC 247057
35 GRAPHIC image_027.jpg GRAPHIC 211353
36 GRAPHIC image_028.jpg GRAPHIC 154463
37 GRAPHIC image_029.jpg GRAPHIC 163623
38 GRAPHIC image_030.jpg GRAPHIC 155887
39 GRAPHIC image_031.jpg GRAPHIC 193575
40 GRAPHIC image_032.jpg GRAPHIC 168165
41 GRAPHIC image_033.jpg GRAPHIC 67963
42 GRAPHIC image_034.jpg GRAPHIC 280685
43 GRAPHIC image_035.jpg GRAPHIC 291551
44 GRAPHIC image_036.jpg GRAPHIC 326832
45 GRAPHIC image_037.jpg GRAPHIC 193617
46 GRAPHIC image_038.jpg GRAPHIC 220437
47 GRAPHIC image_039.jpg GRAPHIC 169405
  Complete submission text file 0001104659-21-037220.txt   10873691

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mrkr-20210311.xsd EX-101.SCH 3190
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrkr-20210311_lab.xml EX-101.LAB 34592
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrkr-20210311_pre.xml EX-101.PRE 22713
48 EXTRACTED XBRL INSTANCE DOCUMENT tm219663d1_8k_htm.xml XML 3615
Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2500 HOUSTON TX 77027
Business Address 3200 SOUTHWEST FREEWAY SUITE 2500 HOUSTON TX 77027 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37939 | Film No.: 21747020
SIC: 2834 Pharmaceutical Preparations